TAMMY WALL: Open Payments
NPI 1245348358 · CORPUS CHRISTI, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$266 in 13 payments from 8 companies in 2025. Trend: 2023 $1,499 · 2024 $1,330 · 2025 $266
Food & beverage: $266
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $69 |
| GlaxoSmithKline, LLC. | 3 | $51 |
| Lilly USA, LLC | 2 | $31 |
| Merck Sharp & Dohme LLC | 1 | $26 |
| Phathom Pharmaceuticals, Inc. | 1 | $24 |
| Abbott Laboratories | 1 | $24 |
| Exact Sciences Corporation | 1 | $21 |
| PFIZER INC. | 1 | $20 |
Products named: SHINGRIX, Ozempic, MOUNJARO, CAPVAXIVE, VOQUEZNA, FREESTYLE LIBRE 3, Wegovy, Cologuard Collection Kit.
Industry payments across TX — which companies pay providers there.
